06.03.26 -- Will FDA's One-Day Inspection Pilot Stand The Test Of Time?

Explore how membrane filtration tools streamline bioburden and microbial enumeration while improving ergonomics and easing routine tasks in fast‑paced pharmaceutical microbiology labs.

See how consistent QC checkpoints show how even degraded samples can produce strong sequencing results when monitored with reliable sizing, quantification, and workflow‑specific thresholds.

Adopt good manufacturing practices with structured onboarding and expert regulatory support. Transition your operations smoothly while maintaining full compliance during scale-up.

Discover how integrated, data-driven solutions can help you reduce downtime, improve visibility, and streamline compliance across your manufacturing operations.

The FDA’s 2026 guidance has put an end to "wellness by disclaimer." Learn how new standards for wearables and apps impact study design, participant safety, and the evolving ethical role of the IRB.

Underestimating E&L risks can delay approvals. A risk‑based, product‑specific approach — supported by strong analytics and toxicology — helps teams identify issues early and move forward with confidence.

Expedited cell therapy pathways demand early, reliable analytical development to ensure robust data, regulatory confidence, and smooth transitions from discovery through clinical stages without costly delays.

Eliminate hidden pathogens and restore facility safety after infrastructure disruptions with these decontamination strategies. Deploy targeted decontamination protocols to protect operational integrity and compliance.

Ensure cleanroom compliance by aligning disinfectant validation with real-world application methods. Justify your protocols and adapt to facility changes with these expert technical insights.

EU GMP Annex 1 is driving meaningful changes in how teams behave inside cleanrooms. Understand what contamination awareness really means in practice and how to build a culture where speaking up is standard.

Leachables risk is a key concern in biomanufacturing. Review best practices for evaluating risks from polymeric single-use systems, including tools and insights to support robust assessments and compliance.